Contribution of the immune response to the pathogenesis of equine herpesvirus-1 (EHV-1): Are there immune correlates that predict increased risk or protection from EHV-1 myeloencephalopathy?
- Journal Article
- Review
Summary
This paper unravels how the immune responses of horses contribute to the pathogenesis of the equine herpesvirus-1 (EHV-1) and identifies any immune correlates that might predict a higher risk or provide protection from EHV-1 myeloencephalopathy (EHM), a rare but severe complication of EHV-1.
Study Objective
The main objective of this review article is to bring attention to how the horse’s immunity plays a role in EHM pathogenesis at various sites of EHV-1 infection. It aims to explore the varying features and interdependence of a horse’s immune response to EHV-1 throughout the infection.
Significance of EHV-1
- Equine herpesvirus-1 or EHV-1 is a common infection among horses causing serious health problems including respiratory disease, abortion in pregnant mares, and EHV-1 myeloencephalopathy, that affects the horse’s central nervous system.
- However, clinical EHM is comparatively rare, affecting only about 10% of horses infected with EHV-1.
- EHM is highly detrimental, thus having considerable economic implications due to loss of the horse’s productivity and high treatment costs.
Correlation of Immune System and EHM
- Although the incidence of EHM relates positively to the duration and magnitude of viremia (the presence of viruses in the blood), it is not the sole determinant of whether EHM occurs or not.
- A combination of certain factors, including host (horse) and viral factors, influence the development of EHM.
- Therefore, identifying these factors is crucial, not only for vaccine development but also for predicting which horses are at higher risk of developing EHM.
In conclusion, this review explores the complexities in the immune response to EHV-1 and its potential implications for managing the fraught consequences of this infection. The findings also suggest prospective areas of future research for vaccine development and protective measures in horses.
Cite This Article
Publication
Researcher Affiliations
- Department of Pathobiology and Diagnostic Investigation, College of Veterinary Medicine, Michigan State University, East Lansing, MI 48824, USA. Electronic address: husseygi@msu.edu.
- Department of Pathobiology and Diagnostic Investigation, College of Veterinary Medicine, Michigan State University, East Lansing, MI 48824, USA. Electronic address: giesslerkim@gmail.com.
MeSH Terms
- Animals
- Herpesviridae Infections / epidemiology
- Herpesviridae Infections / veterinary
- Herpesvirus 1, Equid
- Horse Diseases / epidemiology
- Horses
- Immunity
Citations
This article has been cited 6 times.- Pusterla N, Lawton K, Barnum S, Flynn K, Hankin S, Runk D, Mendonsa E, Doherty T. Management of an Equine Herpesvirus-1 Outbreak During a Multi-Week Equestrian Event. Viruses 2025 Apr 24;17(5).
- de la Cuesta-Torrado M, Vitale V, Velloso Alvarez A, Neira-Egea P, Diss C, Cuervo-Arango J. The Effect of Vaccination Status on Total Lymphocyte Count in Horses Affected by Equine Herpes Virus-1 Myeloencephalopathy. Animals (Basel) 2025 Apr 1;15(7).
- de la Cuesta-Torrado M, Velloso Alvarez A, Cárdenas-Rebollo JM, Neira-Egea P, Vitale V, Cuervo-Arango J. Comparison of clinical variables and outcome of 2 natural equine herpesvirus myeloencephalopathy outbreaks induced by equine herpesvirus-1 A2254/N752 strain in sport horses. J Vet Intern Med 2025 Jan-Feb;39(1):e17287.
- Wang Y, Ma C, Wang S, Wu H, Chen X, Ma J, Wang L, Qiu HJ, Sun Y. Advances in the immunoescape mechanisms exploited by alphaherpesviruses. Front Microbiol 2024;15:1392814.
- Giessler KS, Goehring LS, Jacob SI, Davis A, Esser MM, Lee Y, Zarski LM, Weber PSD, Hussey GS. Impact of the host immune response on the development of equine herpesvirus myeloencephalopathy in horses. J Gen Virol 2024 May;105(5).
- Lunn DP, Burgess BA, Dorman DC, Goehring LS, Gross P, Osterrieder K, Pusterla N, Soboll Hussey G. Updated ACVIM consensus statement on equine herpesvirus-1. J Vet Intern Med 2024 May-Jun;38(3):1290-1299.